Detalhe da pesquisa
1.
Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections.
Nat Commun
; 14(1): 3719, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349337
2.
Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529.
Science
; 376(6591): eabn8897, 2022 04 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35324257
3.
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability.
bioRxiv
; 2022 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35118472
4.
Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability.
Structure
; 30(9): 1233-1244.e7, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841885
5.
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones.
Nat Commun
; 13(1): 7733, 2022 12 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517467
6.
Primary exposure to SARS-CoV-2 variants elicits convergent epitope specificities, immunoglobulin V gene usage and public B cell clones.
bioRxiv
; 2022 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35378757
7.
ß-hydroxybutyrate does not alter the effects of glucose deprivation on breast cancer cells.
Oncol Lett
; 21(1): 65, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33281976
8.
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.
Science
; 373(6556)2021 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34210892
9.
Ultrapotent bispecific antibodies neutralize emerging SARS-CoV-2 variants.
bioRxiv
; 2021 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33821267
10.
Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants.
bioRxiv
; 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655252
11.
Bispecific antibodies targeting distinct regions of the spike protein potently neutralize SARS-CoV-2 variants of concern.
Sci Transl Med
; 13(616): eabj5413, 2021 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34519517